Valuation: H.U. Group Holdings, Inc.

Market Cap 186B 1.15B 1B 924M 849M 1.61B 110B 1.64B 11.03B 4.33B 53.85B 4.3B 4.21B P/E 2027 *
32.8x
P/E 2028 * 20.4x
Enterprise Value 206B 1.27B 1.11B 1.03B 944M 1.79B 123B 1.82B 12.26B 4.81B 59.88B 4.78B 4.68B EV / Sales 2027 *
0.8x
EV / Sales 2028 * 0.76x
Free-Float
96.49%
Yield 2027 *
3.7%
Yield 2028 * 3.71%
1 day+0.03%
1 week+0.87%
Current month+2.46%
1 month+3.84%
3 months+6.06%
6 months-0.06%
Current year-0.18%
1 week 3,320
Extreme 3320
3,400
1 month 3,071
Extreme 3071
3,523
Current year 2,944.5
Extreme 2944.5
3,578
1 year 2,944.5
Extreme 2944.5
4,093
3 years 2,167
Extreme 2167
4,093
5 years 2,167
Extreme 2167
4,093
10 years 2,005
Extreme 2005
5,570
Manager TitleAgeSince
Chief Executive Officer 49 2026-06-15
Director of Finance/CFO - 2026-06-15
Chief Tech/Sci/R&D Officer 63 2026-06-15
Director TitleAgeSince
Director/Board Member 68 2023-06-19
Director/Board Member 79 2018-05-31
Director/Board Member 67 2021-06-22
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%+0.87%+6.26%+22.94% 1.14B
+1.73%+1.09%+85.10%+459.67% 39.05B
-1.34%-2.07%+10.72%+27.83% 22.61B
+0.93%+1.47%-20.55%-39.84% 7.39B
-2.18%-6.37%+10.73%+96.76% 4.94B
-1.22%+4.22%+15.88%+46.26% 3.03B
+5.94%+0.79%-19.04%+884.23% 1.85B
+1.90%+1.83%+110.14%-15.99% 1.85B
+3.85%+22.13%-3.31%-63.38% 1.85B
+3.37%+9.73%+34.98%-18.27% 1.79B
Average +1.30%+2.80%+23.09%+140.02% 8.55B
Weighted average by Cap. +0.67%+0.29%+43.83%+238.45%

Financials

2027 *2028 *
Net sales 257B 1.58B 1.39B 1.28B 1.17B 2.23B 152B 2.26B 15.25B 5.98B 74.5B 5.95B 5.82B 268B 1.66B 1.45B 1.34B 1.23B 2.33B 159B 2.37B 15.95B 6.26B 77.9B 6.22B 6.08B
Net income 5.67B 34.97M 30.58M 28.21M 25.93M 49.13M 3.37B 49.97M 337M 132M 1.64B 131M 128M 8.98B 55.41M 48.44M 44.69M 41.08M 77.84M 5.33B 79.17M 534M 209M 2.61B 208M 204M
Net Debt 20.78B 128M 112M 103M 95.04M 180M 12.33B 183M 1.23B 484M 6.03B 481M 471M 18.84B 116M 102M 93.73M 86.16M 163M 11.18B 166M 1.12B 439M 5.47B 436M 427M
Logo H.U. Group Holdings, Inc.
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Employees
5,157
Date Price Change Volume
26-07-15 ¥3,376.00 +0.03% 67,400
26-07-15 ¥3,375.00 +0.69% 218,800
26-07-14 ¥3,352.00 +0.24% 169,900
26-07-13 ¥3,344.00 -1.09% 190,700
26-07-10 ¥3,381.00 +1.02% 236,900
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,375.00JPY
Average target price
3,156.67JPY
Spread / Average Target
-6.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4544 Stock